Srikanth Nagalla

TitleAssoc Prof CHP
InstitutionThomas Jefferson University
DepartmentNursing - Undergraduate
Phone215-955-8435
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Marshall AL, Masselink LE, Kouides PA, Davies FE, Farooqui A, Nagalla S, Herrera AF, Mortier N, Brodsky RA, Erikson CE. Advanced Practice Providers in Hematology: Actionable Findings from National Paired APP and Physician Surveys. Blood Adv. 2023 Dec 21. PMID: 38127271.
      Citations:    
    2. Sasongko TH, Nagalla S. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2021 12 21; 12:CD009191. PMID: 34932828.
      Citations:    
    3. Williams C, Alweis R, Roth T, Luther V, Pile J, Elkins S, Nagalla S, Muchmore EA. Perspectives on the quality and utility of letters conforming to the AAIM guidelines. J Community Hosp Intern Med Perspect. 2021 Mar 23; 11(2):175-179. PMID: 33889315.
      Citations:    
    4. Al-Samkari H, Nagalla S. Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension. Platelets. 2021 Feb 14; 1-8. PMID: 33586606.
      Citations:    
    5. Reddy MS, Hofmann S, Shen YM, Nagalla S, Rambally S, Usmani A, Sarode R. Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission. Transfus Apher Sci. 2020 Jul 22; 102885. PMID: 32739120.
      Citations:    
    6. Bhatlekar S, Manne BK, Basak I, Edelstein LC, Tugolukova E, Stoller ML, Cody MJ, Morley SC, Nagalla S, Weyrich AS, Rowley JW, O'Connell RM, Rondina MT, Campbell RA, Bray PF. miR-125a-5p Regulates Megakaryocyte Proplatelet Formation Via the Actin Bundling Protein L-Plastin. Blood. 2020 Jul 07. PMID: 32844999.
      Citations:    
    7. Bergstrom CP, Zia A, Sarode R, Nagalla S. Thrombin Generation in a patient with Triple Positive Antiphospholipid Syndrome Treated with Three Different Anticoagulants. Transfus Apher Sci. 2020 May 21; 102815. PMID: 32507383.
      Citations:    
    8. Gobbi G, Carubbi C, Tagliazucchi GM, Masselli E, Mirandola P, Pigazzani F, Crocamo A, Notarangelo MF, Suma S, Paraboschi E, Maglietta G, Nagalla S, Pozzi G, Galli D, Vaccarezza M, Fortina P, Addya S, Ertel A, Bray P, Duga S, Berzuini C, Vitale M, Ardissino D. Sighting acute myocardial infarction through platelet gene expression. Sci Rep. 2019 Dec 20; 9(1):19574. PMID: 31863085.
      Citations:    
    9. Siddiq N, Bergstrom C, Anderson LD, Nagalla S. Bleeding due to acquired dysfibrinogenemia as the initial presentation of multiple myeloma. BMJ Case Rep. 2019 Jul 17; 12(7). PMID: 31320370.
      Citations:    
    10. Siddiq N, Nagalla S, Choi SH. Coagulation Testing in Patients Taking Direct Oral Anticoagulants: A Teachable Moment. JAMA Intern Med. 2019 Jun 24. PMID: 31233085.
      Citations:    
    11. Nagalla S, Sarode R. Role of Platelet Transfusion in the Reversal of Anti-Platelet Therapy. Transfus Med Rev. 2019 Jan 25. PMID: 30814031.
      Citations:    
    12. Eule C, Gupta A, Nagalla S. The Direct Antiglobulin Test for Evaluating Anemia. JAMA. 2018 Dec 03. PMID: 30508030.
      Citations:    
    13. Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2018 Oct 19; 10:CD003426. PMID: 30338520.
      Citations:    
    14. Prokesch BC, Nagalla S, Ezzati F, Tujios SR, Dominguez A, Chen W, Kershaw C, Patel P, de la Flor C, Foster J, Martin AA, de la Morena MT, Wysocki CA. What's in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis. Transfus Apher Sci. 2018 Oct 06. PMID: 30327177.
      Citations:    
    15. Bergstrom C, Nagalla S, Gupta A. Acute Kidney Injury Due to Concomitant Vancomycin and Piperacillin-Tazobactam-Reply. JAMA Intern Med. 2018 Aug 01; 178(8):1137-1138. PMID: 30083742.
      Citations:    
    16. Shen YM, Nagalla S. Hypercoagulable Workup in Thrombotic Cardiovascular Diseases. Circulation. 2018 Jul 17; 138(3):229-231. PMID: 30012700.
      Citations:    
    17. Jain S, Gupta A, Nagalla S. A Mediastinal Mass in a Young Man. JAMA. 2018 06 19; 319(23):2432-2433. PMID: 29922807.
      Citations:    
    18. Bergstrom C, Nagalla S, Gupta A. Management of Patients With Febrile Neutropenia: A Teachable Moment. JAMA Intern Med. 2018 Feb 12. PMID: 29435575.
      Citations:    
    19. Nagalla S, Sarode R. Recent advances in understanding and management of acquired thrombocytopenia. F1000Res. 2018; 7:68. PMID: 29399327.
      Citations:    
    20. Gupta A, Johnson DH, Nagalla S. Antiphospholipid Antibodies. JAMA. 2017 Sep 12; 318(10):959-960. PMID: 28898362.
      Citations:    
    21. Moore JA, Gliga L, Nagalla S. Thyroid storm and warm autoimmune hemolytic anemia. Transfus Apher Sci. 2017 Aug; 56(4):606-608. PMID: 28870408.
      Citations:    
    22. Gupta A, Sarode R, Nagalla S. Thrombophilia Testing in Provoked Venous Thromboembolism: A Teachable Moment. JAMA Intern Med. 2017 Jun 05. PMID: 28586816.
      Citations:    
    23. Sarode R, Agrawal D, Cripps M, Kalva SP, Nagalla S. Re: Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease. J Vasc Interv Radiol. 2017 Jun; 28(6):921-922. PMID: 28532751.
      Citations:    
    24. Geethakumari PR, Mille P, Gulati R, Nagalla S. Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patient with antiphospholipid antibody syndrome. Transfus Apher Sci. 2017 Jun; 56(3):400-403. PMID: 28428030.
      Citations:    
    25. Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2016; 3:CD003426. PMID: 26942338.
      Citations:    
    26. Nagalla S, Bray PF. Personalized medicine in thrombosis: back to the future. Blood. 2016 Jun 2; 127(22):2665-71. PMID: 26847245.
      Citations:    
    27. Geethakumari PR, Sama A, Caro JG, Yeo CJ, Nagalla S. "The Immune Conundrum": Acquired Hemophilia A, Immune Thrombocytopenia, and Neutropenia in a Patient with Pancreatic Cancer. Case Rep Pancreat Cancer. 2016; 2(1):14-18. PMID: 30631809.
      Citations:    
    28. Sasongko TH, Nagalla S, Ballas SK. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2015; 6:CD009191. PMID: 26041152.
      Citations:    
    29. Alistar A, Chou JW, Nagalla S, Black MA, D'Agostino R, Miller LD. Dual roles for immune metagenes in breast cancer prognosis and therapy prediction. Genome Med. 2014; 6(10):80. PMID: 25419236.
      Citations:    
    30. Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, Ma L, Fortina P, Kunapuli S, Holinstat M, McKenzie SE, Dong JF, Shaw CA, Bray PF. Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood. 2014 Apr 17; 123(16):e37-45. PMID: 24523238.
      Citations:    
    31. Edelstein LC, Simon LM, Montoya RT, Holinstat M, Chen ES, Bergeron A, Kong X, Nagalla S, Mohandas N, Cohen DE, Dong JF, Shaw C, Bray PF. Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c. Nat Med. 2013 Dec; 19(12):1609-16. PMID: 24216752.
      Citations:    
    32. Nagalla S, Chou JW, Willingham MC, Ruiz J, Vaughn JP, Dubey P, Lash TL, Hamilton-Dutoit SJ, Bergh J, Sotiriou C, Black MA, Miller LD. Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol. 2013; 14(4):R34. PMID: 23618380.
      Citations:    
    33. Sasongko TH, Nagalla S, Ballas SK. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. Cochrane Database Syst Rev. 2013; 3:CD009191. PMID: 23543572.
      Citations:    
    34. Bray PF, McKenzie SE, Edelstein LC, Nagalla S, Delgrosso K, Ertel A, Kupper J, Jing Y, Londin E, Loher P, Chen HW, Fortina P, Rigoutsos I. The complex transcriptional landscape of the anucleate human platelet. BMC Genomics. 2013; 14:1. PMID: 23323973.
      Citations:    
    35. Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2012; 7:CD003426. PMID: 22786485.
      Citations:    
    36. Yacoub G, Nagalla S, Aklilu M. Oncologic management of hereditary colorectal cancer. Clin Colon Rectal Surg. 2012 Jun; 25(2):118-22. PMID: 23730227.
      Citations:    
    37. Edelstein LC, Luna EJ, Gibson IB, Bray M, Jin Y, Kondkar A, Nagalla S, Hadjout-Rabi N, Smith TC, Covarrubias D, Jones SN, Ahmad F, Stolla M, Kong X, Fang Z, Bergmeier W, Shaw C, Leal SM, Bray PF. Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress. Circulation. 2012 Jun 5; 125(22):2762-71. PMID: 22550155.
      Citations:    
    38. Hong W, Kondkar AA, Nagalla S, Bergmeier W, Jin Y, Herman JH, Bray PF. Transfection of human platelets with short interfering RNA. Clin Transl Sci. 2011 Jun; 4(3):180-2. PMID: 21707948.
      Citations:    
    39. Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, López JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood. 2011 May 12; 117(19):5189-97. PMID: 21415270.
      Citations:    
    40. Nagalla S, Ballas SK. Drugs for preventing red blood cell dehydration in people with sickle cell disease. Cochrane Database Syst Rev. 2010; (1):CD003426. PMID: 20091545.
      Citations:    
    41. Nagalla S, Bray PF. Platelet RNA chips dip into thrombocytosis. Blood. 2010 Jan 7; 115(1):2-3. PMID: 20056796.
      Citations:    
    Nagalla's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (71)
    Explore
    _
    Co-Authors (13)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _